ArticleBMC pediatrics2026
A national multicenter analysis of hospitalization admission records for lymphatic malformation in China from 2016 to 2023.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundLymphatic malformation (LM) is a low-flow vascular malformation caused by the abnormal development of the lymphatic system. This study aimed to provide an update on pediatric LM by investigating its clinical characteristics and hospitalization burden in multiple medical centers across China.
methodsThis study utilized data from the Futang Research Center of Pediatric Development (FRCPD). All hospitalization records from January 1, 2016, to December 31, 2023 (N = 10,974,595) were screened to identify children with LM. For these patients, a comprehensive analysis of clinical characteristics (e.g., demographics, lesion location, treatment, comorbidity/complication and ICU admissions) hospitalization burden (i.e., length of stay and total cost) was conducted.
resultsOur study comprised 24,207 inpatients with LM, predominantly from the eastern region. The typical hospitalized patient was a child aged 1-3 years or on trunk involvement. Strikingly, sclerotherapy was 1.57 times more common than surgical resection. The most frequent comorbidity/complication were infectious diseases. Treatment patterns also varied by anatomy: lesions in the trunk favored surgical resection, while other areas usually undergo sclerotherapy. Critically, hospitalization burden differed significantly based on lesion site, treatment received, and the presence of comorbidity and complication.
conclusionsBy analyzing a national cohort of pediatric inpatients with LM, this study provides contemporary insights into the clinical characteristics and hospitalization burden of this condition in China. These findings underscore the substantial healthcare impact of LM and are critical for informing future healthcare strategies and resource allocation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.